| 日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
| 2008/01/05 | 07 : 35 | PR Newswire (US) | QED International Associates Announces Changes to the HealthShares(TM) Emerging Cancer Index | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
| 2008/01/04 | 04 : 58 | Edgar (US Regulatory) | Coley Pharmaceutical Group, Inc. - Amended Statement of Beneficial Ownership (SC 13D/A) | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
| 2007/12/31 | 23 : 11 | Edgar (US Regulatory) | Coley Pharmaceutical Group, Inc. - Amended tender offer statement by Third Party (SC TO-T/A) | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
| 2007/12/31 | 22 : 00 | Business Wire | Pfizer Inc Announces Completion of the Tender Offer Relating to Outstanding Shares of Coley Pharmaceutical Group, Inc. | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
| 2007/12/22 | 06 : 13 | Edgar (US Regulatory) | Coley Pharmaceutical Group, Inc. - Statement of Beneficial Ownership (SC 13D) | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
| 2007/12/18 | 22 : 32 | Edgar (US Regulatory) | Coley Pharmaceutical Group, Inc. - Amended tender offer statement by Third Party (SC TO-T/A) | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
| 2007/12/18 | 22 : 00 | Business Wire | Pfizer Inc Clears Antitrust Review for Acquisition of All Outstanding Shares of Coley Pharmaceutical Group, Inc. | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
| 2007/12/15 | 06 : 12 | Edgar (US Regulatory) | Coley Pharmaceutical Group, Inc. - Statement of Changes in Beneficial Ownership (4) | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
| 2007/11/30 | 22 : 59 | Edgar (US Regulatory) | Coley Pharmaceutical Group, Inc. - Statement of Ownership: Solicitation (SC 14D9) | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
| 2007/11/30 | 22 : 55 | Edgar (US Regulatory) | Coley Pharmaceutical Group, Inc. - Tender offer statement by Third Party (SC TO-T) | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
| 2007/11/28 | 20 : 04 | Edgar (US Regulatory) | Coley Pharmaceutical Group, Inc. - Written communication by the subject company relating to a third party tender offer (SC14D9C) | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
| 2007/11/27 | 03 : 29 | PR Newswire (US) | Coley Pharmaceutical Group to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
| 2007/11/21 | 06 : 50 | Edgar (US Regulatory) | Coley Pharmaceutical Group, Inc. - Amended Current report filing (8-K/A) | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
| 2007/11/20 | 02 : 58 | Edgar (US Regulatory) | Coley Pharmaceutical Group, Inc. - Amended Statement of Ownership (SC 13G/A) | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
| 2007/11/17 | 06 : 15 | Edgar (US Regulatory) | Coley Pharmaceutical Group, Inc. - Current report filing (8-K) | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
| 2007/11/17 | 04 : 30 | Edgar (US Regulatory) | Coley Pharmaceutical Group, Inc. - Written communication by the subject company relating to a third party tender offer (SC14D9C) | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
| 2007/11/17 | 00 : 54 | Edgar (US Regulatory) | Coley Pharmaceutical Group, Inc. - Written communication by the subject company relating to a third party tender offer (SC14D9C) | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
| 2007/11/16 | 23 : 35 | Edgar (US Regulatory) | Coley Pharmaceutical Group, Inc. - Written communication relating to an issuer or third party (SC TO-C) | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
| 2007/11/02 | 05 : 05 | PR Newswire (US) | Coley Pharmaceutical Group Reports Third Quarter and Nine-month Financial Results | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
| 2007/11/01 | 03 : 24 | PR Newswire (US) | Coley Pharmaceutical Group to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
| 2007/10/30 | 22 : 00 | PR Newswire (US) | Coley Pharmaceutical Group and Pfizer Nominate Additional Anti-Cancer Compound for Clinical Development | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
| 2007/10/29 | 22 : 00 | PR Newswire (US) | Coley Pharmaceutical Group Diversifies Pipeline with First-in-Class TLR Antagonist for the Treatment of Systemic Lupus Erythemat | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
| 2007/10/27 | 00 : 34 | PR Newswire (US) | Coley Pharmaceutical Group Receives $3.0 Million Milestone Payment from GlaxoSmithKline | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
| 2007/10/25 | 21 : 30 | PR Newswire (US) | Coley Pharmaceutical Group to Report Third Quarter Results on November 1, 2007 | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
| 2007/10/09 | 21 : 11 | Edgar (US Regulatory) | Coley Pharmaceutical Group, Inc. - Securities Registration (section 12(b)) (8-A12B) | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
| 2007/10/09 | 21 : 09 | Edgar (US Regulatory) | Coley Pharmaceutical Group, Inc. - Current report filing (8-K) | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
| 2007/10/08 | 21 : 30 | PR Newswire (US) | Coley Pharmaceutical Group Adopts Shareholder Rights Plan | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
| 2007/09/21 | 04 : 18 | Edgar (US Regulatory) | Coley Pharmaceutical Group, Inc. (Other) (4) | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
| 2007/09/21 | 04 : 18 | Edgar (US Regulatory) | Coley Pharmaceutical Group, Inc. (Other) (4) | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
| 2007/09/21 | 04 : 17 | Edgar (US Regulatory) | Coley Pharmaceutical Group, Inc. (Other) (4) | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |